Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Fat injections in the face can cause hair loss.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Syphilitic alopecia, linked to syphilis and high-risk sexual behavior, improves with penicillin treatment.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

PRP and cell therapies may help with hair loss, but more research is needed.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Ingesting Leucaena leucocephala caused hair loss and increased infant mortality in ringtailed lemurs.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

A genetic marker linked to a type of hair loss was found in most patients studied.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.